Skip to main content
Livermore
Livermore
ZHEN

Sierra Oncology, Inc.

SRRADelisted Jul 1, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001290149

Sierra Oncology, Inc. was delisted on Jul 1, 2022; its insiders filed their last Form 4 on Jul 1, 2022; 109 institutions reported holding it in 13F filings for Q2 2022, worth $1.23B in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Sierra Oncology, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of SRRA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders34137+4
Shares9.03M1.04K10.6M+1.61M (+17.8%)
Value$171.8M$20.0K$233.1M+$61.2M (+35.6%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Sierra Oncology, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to SRRA in Q3 2021
InstitutionSharesValue% of portfolio
Vanguard Group Inc229,258$5.03M0.00%
Two Sigma Advisers, LP42,656$935.0K0.00%
Two Sigma Investments, LP22,401$491.0K0.00%
Geode Capital Management, LLC10,075$220.0K0.00%
Jackson Square Capital, LLC9,152$201.0K0.07%
JPMorgan Chase & Co100$2.00K0.00%
O'Shaughnessy Asset Management, LLC41$1.00K0.00%

Sold out (3)

Institutions that held Sierra Oncology, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of SRRA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Perceptive Advisors LLC66,655$1.30M
Telemetry Investments, L.L.C.12,349$241.0K
Strategic Blueprint, LLC782$15.0K

Not filed for Q3 2021 yet (1)

Institutions that held Sierra Oncology, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SRRA in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Elmwood Wealth Management, Inc.1,040$20.0K